In an era marked by remarkable advances in antiretroviral therapy (ART), the survival and quality of life of individuals living with HIV have dramatically improved. Yet, new research is now illuminating the complex interplay between immune system dysregulation and the emergence of cardiovascular disease (CVD) in a particularly vulnerable population: adolescents infected with HIV perinatally. A groundbreaking study, published in Nature Communicat…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.